With this fresh funding, Dozee plans to expand further in the Indian market and invest more in its differentiated R&D capabilities. In addition, the funding will provide a springboard for the company’s global expansion
Dozee has raised $6 million as part of its Series A2 funding. The round saw the infusion of funds from Dozee’s existing investor base consisting of Prime Venture Partners, 3one4 Capital, YourNest VC, and new investors which include State Bank of India, J&A Partners Family office, and Dinesh Mody Ventures (ex-JB Chemicals and Pharmaceuticals promoters – Sharan Asher & Pranabh Mody). Dozee has established a presence in over 380+ hospitals covering 50+ districts.
Its key recent milestones include the US FDA 510(k) clearance for its flagship Remote Patient Monitoring product – Dozee Contactless Vital Signs (VS) Measurement system, further demonstrating its commitment to Made in India, with global standards. USFDA is the gold standard for medical devices and algorithms.
With this fresh funding, Dozee plans to expand further in the Indian market and invest more in its differentiated R&D capabilities. In addition, the funding will provide a springboard for the company’s global expansion.
“Dozee plans to further tap over 2,000 hospitals in more than 100 districts in the next two years to improve the quality of critical care facilities in India. The current Series A2 fund-raise is a part of the company’s plan to further its reach to every nook and corner of the country and to begin the era of ‘Made in India’ products in the global market. In the last couple of years, Dozee has grown tremendously, but our growth journey is just beginning, and there is still much more to do. Our growth momentum demonstrates accelerating progress toward our goal of making ‘HarBedDozeeBed’ the future of Indian healthcare infrastructure.“ said Mudit Dandwate, CEO & Co-Founder, Dozee.
- Advertisement -